Gland Pharma Ltd GLAND.NS
₹2,970.20 ₹19.80 (0.67%) 1D
Last Updated: Aug 14, 12:00 AM·NSE
Pricing for IN stocks is delayed by 24 hours
GLAND.NS Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Gland Pharma Ltd is classified as halal.
HALAL
Report Source: undefined Quarter Report
Gland Pharma Ltd. Stock Analysis GLAND.NS
India Health Care Mid Cap Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. The firm specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, New Chemical Entities (NCE)-1s, First-to-File products, and 505(b)(2) filings. The firm manufactures a range of dosage formulations, including solutions, suspensions, and lyophilized products. Its product portfolio includes delivery methods such as pre-filled syringes, vials, ampoules, bags, and dry powder injections. The company also produces generic injectables in liquid, lyophilized, suspension, and pre-filled syringe forms. Its molecules include Enoxaparin Sodium, Cisplatin, Lacosamide, Rocuronium Bromide, Zoledronic Acid, Vancomycin, and others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynecological, Hormones, and others. The firm functions primarily on a business-to-business model. Its subsidiary is Gland Pharma International Pte. Ltd.
Gland Pharma Ltd (GLAND.NS) Chart
Financial Metrics & Statements of Gland Pharma Ltd (GLAND.NS)
FAQ's for Gland Pharma Ltd (GLAND.NS)
- As of August 2026, Gland Pharma Ltd GLAND.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Gland Pharma Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Gland Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Gland Pharma Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Gland Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Gland Pharma Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Gland Pharma Ltd (GLAND.NS)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
